Every JSE small-cap investor has experienced this. A company you own reports disappointing results. Revenue falls. Earnings miss expectations.
The share price drops 30% in a day. Before asking whether you should sell, ask a different question: Is this demand destruction or demand deferral?
It sounds like a subtle distinction. It isn’t. It’s the difference between a business that’s permanently deteriorating and one suffering a temporary setback. Investors who can tell the difference often buy when everyone else is selling.
The mistake the market makes
Imagine a JSE-listed technology services business with a handful of major clients and a strong track record.
Its half-year results disappoint. Revenue is down 18%. HEPS falls from 42c to 28c. Management says contract renewals were delayed and new project approvals slowed.
The market assumes the worst and the share price falls 35%.
But a closer look tells a different story.
Two major clients didn’t cancel their contracts. They postponed them. One was waiting for board approval on a larger IT budget. The other had frozen procurement while completing a merger. Neither customer switched to a competitor. Both still intended to proceed.
The order book for the next period was actually larger than a year earlier.
The business hadn’t broken. The timing had.
Investors who couldn’t distinguish between the two sold at the bottom.
Demand destruction versus demand deferral
Demand destruction occurs when customers no longer want what you sell. They’ve moved to a competitor, the market has changed, or your product has become less relevant. Lost revenue is unlikely to return, so a lower valuation is justified.
Demand deferral is different. Customers still want the product but postpone spending because of a temporary issue, a budget freeze, merger, cash-flow pressure or macro uncertainty. Revenue is delayed rather than lost.
The investment implications couldn’t be more different.
A business experiencing demand destruction deserves a lower valuation. The earnings stream it was being priced on no longer exists in the form the market assumed. Some of the share price fall is correct.
A business experiencing demand deferral deserves patience. The earnings are still coming. They’ve been delayed. The share price fall, if it occurs, is an opportunity rather than a warning.
On the JSE, in thinly traded small caps with limited analyst coverage and a shareholder base that reacts quickly to disappointing numbers, these two situations look identical in the short-term results.
The skill is knowing which one you’re actually looking at.
Why this matters even more in JSE small caps
Small caps are particularly vulnerable to timing issues.
One delayed contract can reduce earnings dramatically. With limited analyst coverage and thin trading volumes, a few disappointed shareholders can push the share price down 20% or 30% very quickly.
The encouraging part is that recoveries work the same way.
When delayed contracts are signed and deferred revenue flows through, earnings often rebound sharply. In illiquid small caps, the rerating can be just as fast as the sell-off.
The investors who held through the deferral, who understood what was actually happening and didn’t sell at the bottom, capture that entire recovery. The investors who couldn’t tell the difference from destruction sold into the fear and missed it.
Four questions to ask before selling
Whenever a small cap reports disappointing numbers, work through these four questions.
1. Was the customer lost or was the decision delayed?
“Contract delayed” and “contract cancelled” are very different statements. Pay attention to management’s language.
2. Is the cause temporary or permanent?
Budget freezes, mergers and macro uncertainty eventually pass. Losing a major customer to a competitor or facing structural industry decline usually doesn’t.
3. Is the order book still healthy?
If the forward pipeline remains stable or continues growing, demand may simply have shifted into a later period. A shrinking pipeline is a more serious warning sign.
4. Can management clearly explain what happened?
Strong management teams identify specific causes and explain why they expect conditions to improve. Vague references to “challenging conditions” deserve greater scepticism.
What to do right now
The JSE small cap results season running through July and August is going to produce disappointing numbers.
Some will be demand destruction – businesses genuinely losing ground that won’t be recovered. Those deserve a lower share price and deserve to be reviewed seriously.
But some will be demand deferral – businesses whose clients have temporarily redirected spending, whose contracts have slipped a quarter, whose revenue has been pushed to the right by a short-term constraint that will eventually lift.
Those are not reasons to sell. They may be reasons to buy more.
Read the next disappointing announcement carefully. Ask the four questions. Look for the order book. Read the management commentary for specific language versus vague reassurance. And before you join the market in selling 30% lower, make sure you understand which one you’re actually looking at.
The biggest opportunities on the JSE don’t always arrive as an obviously cheap valuation or a glowing set of results. Sometimes they arrive dressed as a disappointing interim period, and they belong to investors patient enough and analytical enough to see through the surface to what’s actually happening underneath.
Not a subscriber to Money Morning?
You can get free daily recommendations like these with Money Morning eletter. Just sign up here.
